Search Results 151-160 of 4352 for 搜索痕迹咨询邮箱：lgooxc@hotmail.com

  1. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...

  2. Contact - Allergic Diseases: Hirohito Kita - Mayo Clinic Research

    Hirohito Kita, M.D. · Principal Investigator · Allergic Diseases Laboratory · Mayo Clinic · 13400 E. Shea Blvd. · Scottsdale, AZ 85259 · Phone: 480-301-9616 · Email: ...

  3. Contact us - Mayo Clinic

    For information about making a gift, call 855-852-8129. To request a medical appointment, see Appointments at Mayo Clinic. Email. development@mayo.edu. Mail.

  4. A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Participants with Mycobacterium Avium Complex (MAC) Pulmonary Disease - Mayo Clinic

    About this study. The purpose of the study is to evaluate the microbiological response and clinical effectiveness of SPR720 compared with placebo in ...

  5. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  6. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...

  7. Application Process - Multiple Sclerosis and Autoimmune Neurology Fellowship (Arizona) - Mayo Clinic College of Medicine & Science

    This must be completed in the Recommendation Request section. The recommender will receive an email with a link to upload a letter. Applicants considered for an ...

  8. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  9. https://www.mayoclinic.org/arabic_patient_consumer_web.xml

  10. John M. Sheele, M.D., M.H.S., M.P.H. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher John M. Sheele, M.D., M.H.S., M.P.H., is an emergency medicine doctor who studies infectious diseases, global health and wilderness ...